RenovoRx logo

RenovoRx (RNXT) Q1 2026 Earnings

RNXT·Reported May 14, 2026·After market close

RenovoRx reported Q1 2026 revenue of $563.0K (+185.8% YoY), beat analyst consensus of $469.5K by $93.5K. Diluted EPS came in at $-0.08 (+0.0% YoY).

Revenue
$563.0Kbeat by $93.5K
Consensus: $469.5K
Diluted EPS
$-0.08met estimate
Consensus: $-0.08
SEC

SEC Filings

Earnings release8-K · 0001193125-26-224080
Quarterly report10-Q · 0001193125-26-224100

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about RenovoRx's Q1 2026 earnings report.

RenovoRx (RNXT) reported Q1 2026 earnings on May 14, 2026 after market close.

RenovoRx reported revenue of $563.0K and diluted EPS of $-0.08 for Q1 2026.

Revenue beat the consensus estimate of $469.5K by $93.5K. EPS beat the consensus estimate of $-0.08 by $0.00.

Compared to the same quarter a year prior, revenue grew 185.8% from $197.0K a year earlier and diluted EPS grew 0.0% from $-0.08.

You can read the 8-K earnings release (0001193125-26-224080) and the 10-Q periodic report (0001193125-26-224100) directly on SEC EDGAR. The filing index links above go to sec.gov.